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Low dietary inclusion 
of nutraceuticals from microalgae 
improves feed efficiency 
and modifies intermediary 
metabolisms in gilthead sea bream 
(Sparus aurata)
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The aim of this work was to evaluate two functional feeds for the gilthead seabream, Sparus 
aurata, containing low inclusion of two microalgae‑based products (LB‑GREENboost,  LBGb; and 
LB‑GUThealth,  LBGh). Fish (12–13 g) were fed for 13 weeks a control diet or one of the four diets 
supplemented with both products at 0.5% or 1%.  LBGb and  LBGh did not affect specific growth rate or 
survival, but increased feed efficiency by decreasing feed intake and enlarging the intestines.  LBGb 
increased hepatosomatic index and reduced cortisol levels in plasma, while both products lowered 
plasma lactate. Extensive metabolite and metabolic enzyme profiling revealed that microalgae 
supplementations, especially 1%  LBGh: (i) decrease plasma lactate and increase hepatic glycogen, (ii) 
reduce hepatic gluconeogenesis, (iii) enhance hepatic lipogenic activity and lipid secretion, (iv) led fish 
to double triglyceride content in muscle and to stimulate its lipid oxidative capacity, and (v) increase 
the content of monounsaturated fatty acids and the omega‑3 alpha‑linolenic acid in muscle. This 
study demonstrates that both microalgae‑based products are suited to improve feed efficiency and 
orchestrate significant changes in the intermediary metabolism in gilthead seabream juveniles.
World aquaculture production is continuously growing at a high rate, but the European industry is stagnant 
and needs to advance to a more competitive and high-performance industry, while ensuring high level of 
 sustainability1. One major issue related with both economic and environmental sustainability is the replace-
ment of fish meal (FM) and fish oil (FO) in aquafeeds. Significant achievements have been made during the last 
decade, and the fish aquaculture industry has significantly reduced the dependence on these marine ingredients 
by incorporating balanced mixtures of plant meals and oils in feed  formulations2–5, and higher replacement rates 
are expected through the use of novel alternatives such as genetically engineered oilseed crops and the use of 
 microalgae6.
Microalgae and microalgae-derived products are rich in  proteins7 and lipids with high amount of highly 
unsaturated fatty  acids8, thus they have been evaluated in different fish species as alternatives for FM and 
FO. Several studies indicated that microalgae inclusion in freshwater fish diets does not affect growth  rate9,10, 
or can induce positive effects on their growth, metabolism, and meat  quality11. Results are more variable in 
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salmonids and marine fish, depending on the microalgae species employed and the level of inclusion in diet (e.g. 
 salmonids12–14, gilthead sea  bream15–17). Although the inclusion of high level of microalgae in most fish feeds is 
still limited by high production costs, different companies have announced algae-based products to be used in 
high-valued commercial fish (e.g. salmonids) as alternatives to  FO6, and different products (e.g. AlgaPrimeDHA) 
are already being produced at large-scale through fermentation-based  technologies18.
While the use of microalgae-derived products as alternative raw material in fish feeds has received most of 
the attention, there is also an increasing interest in their use as functional feed additives. In this sense, the use 
of microalgae products at relatively low level (< 10%) in fish functional feeds has the potential to improve aqua-
culture production by enhancing growth and/or feed  efficiency19–21, two features that have been traditionally 
improved through the optimization of feed formulations and feeding practices. Feed efficiency, in particular, is 
difficult to increase using phenotypic trait selection. Other aspects that can be improved by the use of functional 
feeds are wellbeing, health, stress resistance, or product quality, which are also of a great interest today for both 
producers and consumers. Functional feeds (or nutraceutical components in feed) trigger, by definition, beneficial 
effects upon physiological  functions22. Bioactive compounds from microalgae such as protein, polyunsaturated 
fatty acids, polysaccharides, carotenoids, vitamins and minerals, phenolic compounds, volatile compounds, and 
sterols play important roles in functional feeds for both humans and  livestock20,23,24. The most widely microalgae-
derived product used by the aquaculture industry is astaxanthin, mainly to improve the coloration, but also other 
important physiological  processes25. However, different microalgae have immunostimulating and health pro-
moting effects properties in  fish26, or improve growth and fillet  quality27. For instance, the addition of moderate 
levels (~ 10%) of a Chlorella-derived product in feed is able to ameliorate plat-induced enteritis in  salmonids28, 
and ~ 4.5–5.0% inclusion of Isochrysis galbana biomass in diets for the marine fish Trachinotus ovatus, improves 
growth performance, lipid deposition and content of muscular n-3 fatty acids, DHA, and  EPA27.Yet, studies on 
microalgae-derived products used at lower inclusion levels in diets for farmed fish are scarce, despite this would 
have a positive impact on feed cost. In other livestock such as broiler chicks, feed supplementation with only 
0.1–0.2% of microalgae products, considered as a very-low inclusion level, produces positive effects such as the 
improvement of fatty acid composition of meat without affecting the growth  performance29.
The aim of this work was to evaluate the potential benefits of two functional feeds for the gilthead seabream, 
which contain low level of two microalgae-based products, LB-GREENboost  (LBGb) and LB-GUThealth  (LBGh), 
developed by LifeBioencapsulation S.L., a spin-off from the University of Almería (Spain). The gilthead seabream 
is one of the main fish species farmed in Europe, especially in the Mediterranean region. In particular, the effects 
of low dietary inclusion (0.5% and 1%) of these products on growth performance, nutrient utilization, and 
intermediary metabolism were studied after a 13-week feeding trial. This study shows that the products evalu-
ated are suited for improving some important indicators of culture performance and physiological condition of 
gilthead seabream juveniles, thus revealing the potential for their inclusion in new functional feeds for this, or 
even others cultured species.
Material and methods
Ethics. Fish were kept and handled following the guidelines for experimental procedures in animal research 
of the Ethics and Animal Welfare Committee of the University of Cadiz, according to the Spanish (RD53/2013) 
and European Union (2010/63/UE) legislation. The Ethical Committee from the Autonomous Andalusian Gov-
ernment approved the experiments (Junta de Andalucía reference number 04/04/2019/056).
Diets. Five isoproteic, isolipidic and isoenergetic diets were formulated with a composition that is close to that 
of commercial feeds for the gilthead seabream, and produced at the University of Almería facilities (Experimen-
tal feeds Service; https ://www.ual.es/stecn icos_spe). FM and FO were included at 20% and 9.2%, respectively, 
in all experimental diets. This formulation constituted the control diet (CTRL). In addition, two commercial 
compounds extracted from microalgae, (i) LB-GREENboost  (LBGb) and (ii) LB-GUThealth  (LBGh) developed by 
LifeBioencapsulation S.L. (Almería, Spain), were added at 0.5% and at 1%, constituting the four supplemented 
diets (Table 1).  LBGb (crude protein 57.0%, crude fat 6.4%, crude fibre 0.4%, crude ash 9.4%, and moisture 7.0%) 
and  LBGh (crude protein 56.0%, crude fat 2.0%, crude fibre 0.2%, crude ash 12.7%, and moisture 8.8%) are con-
centrated mixtures containing 800 g kg−1 and 200 g kg−1, respectively, of a blend of microalgae extracts. The rest 
of compounds used in those commercial products are lipotropic substances (choline and betaine) and calcium 
carbonate used as excipients. The ingredient composition and fatty acid profile of experimental diets are shown 
in Tables 1 and 2, respectively.
Feeding protocol and sampling procedures. After an initial acclimation period (10 days) to the exper-
imental facility (CTAQUA, El Puerto de Santa María, Cádiz, Spain), gilthead sea bream juveniles with 12–13 g 
of initial mean body weight were randomly distributed in fifteen 100-L tanks (n = 30 fish per tank, 90 fish per 
experimental diet) coupled to a recirculation aquaculture system (RAS), equipped with physical and biological 
filters, and programmable temperature and  O2 devices. Water temperature was set constant at 22 ± 0.5 ºC. Oxy-
gen content of outlet water remained higher than 85% saturation, and day-length followed the natural changes 
at our latitude (36º35′06″ N; 06º13′48″ W). Experimental diets were offered to visual satiety three times per day 
and 6 days per week from February to May (13-week feeding trial). Fish were counted and group-weighed every 
3 weeks, and feed intake was recorded for each experimental replicate to calculate growth performance param-
eters. No mortalities were registered in any experimental group.
At the end of the trial (day 87), overnight fasted fish (4 fish per tank, 12 per experimental condition) were 
randomly selected, deeply anaesthetised with clove oil, and then sampled for blood and tissue collection. Blood 
was drawn from caudal vessels with heparinised syringes, centrifuged at 3000×g for 20 min at 4 ºC, and plasma 
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samples were snap-frozen in liquid nitrogen and stored at − 80 ºC until biochemical and hormonal analysis. 
Prior to tissue collection, fish were killed by cervical section, and livers were extracted and weighed. Intestine 
was taken for length measurements. Samples of liver and white skeletal muscle were rapidly taken, snap-frozen 
in liquid nitrogen, and stored at − 80 ºC until biochemical analyses.
Growth performance and biometric parameters. The following growth parameters were evalu-
ated: (i) specific growth rate (SGR) = (100 × (ln final body weight − ln initial body weight)/days; (ii) weight gain 
(WG) = (100 × (body weigh increase)/initial body weight; (iii) feed efficiency (FE) = weight gain/total feed intake; 
and (iv) condition factor = (100 × body weight)/fork length. Biometric indices were estimated in accordance 
with the following equations: (i) Hepatosomatic index (HSI) = (100 × liver weight)/fish weight; and (ii) Intestine 
length index (ILI) = (100 × Li)/Lb, where  Li and  Lb are the intestine and fork body length, respectively.
Biochemical parameters of the plasma. Plasma cortisol levels were measured with a commercial Cor-
tisol Enzyme Immunoassay Kit from ARBORASSAYS (NCAL International Standard Kit, DETECTX, K003). 
Glucose, lactate and triglycerides levels in plasma were measured using commercial kits from SPINREACT (St. 
Esteve de Bas, Girona, Spain) adapted to 96-well microplates. Plasma total protein concentration was deter-
mined with a BCA Protein AssayKit (PIERCE, Thermo Fisher Scientific, USA, #23225) using BSA as the stand-
ard. All assays were performed using a POWERWAVE 340 microplate spectrophotometer (Bio-Tek Instruments, 
Winooski, VT, USA) using the KCJUNIOR data analysis software for MICROSOFT.
Table 1.  Ingredients and chemical composition of the experimental diets. CTRL: control;  LBGb0.5: 
LB-GREENboost (0.5%);  LBGb1: LB-GREENboost (1%);  LBGh0.5: LB-GUThealth (0.5%);  LBGh1: LB-GUThealth 
(1%). a 69.4% crude protein, 12.3% crude lipid (Norsildemel, Bergen, Norway). b,c,h,k Lorca Nutricion Animal 
S.A. (Murcia, Spain). d 45% crude protein, 9% crude lipid (Bacarel, UK). e 78% crude protein, 1% ash, 
105 moisture (Lorca Nutricion Animal S.A., Murcia, Spain). f 65% crude protein, 8% crude lipid (DSM, 
France). g AF117DHA (Afamsa, Spain). i P700IP (Lecico, DE). j Local provider (Almería, Spain). l Provided 
by Lifebioencapsulation S.L.Vitamins (mg kg−1): vitamin A (retinyl acetate), 2,000,000 UI; vitamin D3 
(DL-cholecalciferol), 200,000 UI; vitamin E (Lutavit E50), 10,000 mg; vitamin K3 (menadione sodium 
bisulfitete), 2500 mg; vitamina B1(thiamine hydrochloride), 3000 mg; vitamin B2 (riboflavin), 3000 mg; 
calcium pantothenate, 10,000 mg; nicotínico acid, 20,000 mg; vitamin B6 (pyridoxine hydrochloride), 
2000 mg; vitamin B9 (folic acid), 1,500 mg; vitamin B12 (cyanocobalamin), 10 mg vitamin H (biotin), 300 mg; 
inositol, 50,000 mg; betaine (Betafin S1), 50,000 mg. Minerals (mg kg−1): Co (cobalt carbonate), 65 mg; Cu 
(cupric sulfate), 900 mg; Fe (iron sulFate), 600 mg; I (potassium iodide), 50 mg; Mn (manganese oxide), 
960 mg; Se (sodium selenite), 1 mg; Zn (zinc sulphate) 750 mg; Ca (calcium carbonate), 18.6%; (186,000 mg); 
KCl, 2.41%; (24,100 mg); NaCl, 4.0% (40,000 mg). m,n,o EPSA, Spain.
CTRL LBGb0.5 LB Gb1 LBGh0.5 LBGh1
Ingredient composition (g kg−1)
Fish meal LT-94a 200 200 200 200 200
Lysineb 12 12 12 12 12
Methioninec 5 5 5 5 5
LB-GREENboost  (LBGb) – 5 10 – –
LB-GUThealth  (LBGh) – – – 5 10
Krill  meald 25 25 25 25 25
Gluten  wheate 130 130 130 130 130
Soybean protein  concentratef 342 342 342 342 342
Fish  oilg 92 92 92 92 92
Soybean  oilh 44 44 44 44 44
Soybean  lecithini 10 10 10 10 10
Wheat  mealj 94 89 84 89 84
Betaink 5 5 5 5 5
Vitamin and mineral  premixl 20 20 20 20 20
Vitamin  Cm 1 1 1 1 1
Guar  gumn 10 10 10 10 10
Alginateo 10 10 10 10 10
Proximate composition (g kg−1)
Moisture 90.3 89.7 90.5 89.6 88.9
Crude protein 462.1 458.7 459.4 460 463.6
Crude lipid 184.2 182.3 180.7 179.3 178.2
Ash 99.4 102.7 104.8 98.5 103.0
Nitrogen free extract 254.5 256.3 255.5 262.2 255.2
4
Vol:.(1234567890)
Scientific Reports |        (2020) 10:18676  | https://doi.org/10.1038/s41598-020-75693-3
www.nature.com/scientificreports/
Biochemical parameters of the liver and muscle. Frozen tissues used for the assay of metabolites 
were homogenized by ultrasonic disruption in 7.5 volumes ice-cold 0.6 N perchloric acid, neutralized using 1 M 
 KCO3, centrifuged (30 min, 3220×g and 4 ºC), and then supernatants isolated to determine tissue metabolites. 
Tissue triglycerides and lactate levels were determined spectrophotometrically with commercial kits (SPIN-
REACT, see above). Tissue glycogen concentration was quantified using the method described  from30, where 
glucose obtained after glycogen breakdown with amyloglucosidase (SIGMA-ALDRICH A7420) was determined 
with a commercial kit (SPINREACT) as described before.
Activity of metabolic enzymes in liver and muscle. Frozen tissues for enzyme activity assays were 
homogenized by ultrasonic disruption in 10 volumes of ice-cold homogenization buffer (50  mM imidazole, 
1  mM 2-mercaptoethanol, 50  mM NaF, 4  mM EDTA, 0.5  mM phenylmethylsulfonyl fluoride (PMSF) and 
250 mM sucrose; pH 7.5). Homogenates were centrifuged for 30 min at 3220×g and 4  ºC, and supernatants 
stored at − 80 ºC for further analysis. The assays of several enzymes involved in glycogenolysis (GPase [i.GPtotal 
and ii.GPactive]: glycogen phosphorylase, EC 2.4.1.1), glycolysis (HK: hexokinase, EC 2.7.1.1; PK: pyruvate 
kinase, EC 2.7.1.40; G3PDH: glycerol-3-phosphate dehydrogenase, EC 1.1.1.8), gluconeogenesis (LDH: lac-
tate dehydrogenase, EC 1.1.1.27; FBP: fructose 1,6-bisphosphatase, EC 3.1.3.11), Krebs Cycle (MDH: malate 
dehydrogenase, EC 1.1.1.37), pentose phosphate pathway (G6PDH: glucose-6-phosphate dehydrogenase, EC. 
1.1.1.49), and lipid metabolism (HOAD: 3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.35) were performed as 
previously described for S. aurata  tissues31–34. Enzyme activities were determined using a POWERWAVE 340 
microplate spectrophotometer using the KCJUNIOR data analysis software for MICROSOFT. Activities were 
expressed as specific activities per mg of protein in the homogenate (U mg  prot−1). Proteins were assayed in 
duplicate, as described above for plasma samples.
Table 2.  Fatty acid content (g fatty acid  kg−1) of the microalgae additives LB-GREENboost (LBGb) and 
LB-GUThealth (LBGh), and fatty acid profiles (% total fatty acids) of the experimental diets (% of total FAs). 
LBGb0.5: LB-GREENboost (0.5%); LBGb1: LB-GREENboost (1.0%); LBGh0.5: LB-GUThealth (0.5%); LBGh1: 




 kg−1) Experimental diets (% total fatty acids)
LBGb LBGh CTRL LBGb0.5 LBGb1 LBGh0.5 LBGh1
14:0 4.61 1.32 2.11 2.10 2.11 2.11 2.12
16:0 12.39 3.54 16.43 16.94 16.90 16.45 16.39
18:0 2.15 0.61 5.25 5.49 5.24 5,15 5,17
16:1n7 6.62 1.89 3.09 3.04 3.06 3.10 3.11
18:1n7 0.15 0.04 1.88 1.83 1,85 1.87 1.85
18:1n9 4.38 1.25 19,76 20.27 20.27 20.28 20.29
20:1n9 nd nd 1.16 1.18 1.15 1.10 1.09
16:2n4 1.24 0.35 0.58 0.56 0.58 0.56 0.57
18:2n6 4.59 1.31 24.47 23.27 23.57 24.36 24.34
18:3n3 11.17 3.19 1.20 1.30 1.28 1.26 1.23
16:3n4 0.85 0.24 0.43 0.41 0.42 0.42 0.43
18:4n3 8.93 2.55 0.56 0.67 0.61 0.51 0.51
20:4n6 0.63 0.18 1.17 1.13 1.12 1.17 1.16
20:4n3 nd nd 0.40 0.38 0.38 0.40 0.40
20:5n3, EPA 3.05 0.87 4.22 4.15 4.14 4.14 4.15
22:5n3 0.71 0.20 1.18 1.13 1.11 1.12 1.13
22:6n3, DHA 2.32 0.66 12.70 12.45 12.46 12.49 12.50
∑SFA 23.79 24.52 24.24 23.72 23.69
∑MUFA 25.88 26.33 26.34 26.35 26.33
∑PUFA 45.91 44.48 44.67 45.47 45.43
Other FA 3.42 3.70 3.75 3.48 3.56
∑n-3 20.26 20.08 19.98 19.93 19.93
∑n-6 25.65 24.40 24.69 25.53 25.50
∑n-9 20.91 21.45 21.42 21.38 21.38
n3/n6 0.79 0.82 0.81 0.78 0.78
EPA/DHA 0.33 0.33 0.33 0.33 0.33
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Proximate composition and fatty acids analysis. Proximate analysis (dry matter, ash, and total pro-
tein, N × 6.25) of feed and muscle samples were determined according  to35 procedures. Lipids were extracted fol-
lowing the Folch  method36 using chloroform/methanol (2:1 v/v) as solvent, and total lipid content was calculated 
gravimetrically. Fatty acid (FA) profile was determined by gas chromatography following the method described 
 in37, by means of a gas chromatograph (HEWLETT PACKARD, 4890 Series II, Hewlett Packard Company, 
Avondale, PA), using a modification of the direct transesterification method described  by38 that involves no prior 
separation of the lipid fraction.
Statistical analyses. Results are shown as mean ± standard error of the mean (mean ± SEM). After assess-
ing homogeneity of variance and normality, statistical analysis of the data was carried out using one-way analysis 
of variance followed by the Tukey test. A comparison of triplicate tanks for all parameters was also performed 
with one-way analysis of variance. The level of significance was set at p < 0.05. All tests were performed using 
GRAPHPAD PRISM (v.5.0b) software for Macintosh.
Results
Growth performance and biometric parameters. No mortality occurred during the experiment. In 
addition, all fish groups grew allometrically from 12–13 g to 37–39 g with an overall weigh gain (WG) of ~ 200% 
and specific growth rates (SGR) of 1.26–1.30% (Table 3). Diet supplementation significantly reduced feed intake 
(Fig. 1a) with the subsequent increase of feed efficiency from 0.81 (control group) to 0.87–0.92 in fish fed both 
compounds  (LBGb and  LBGh) and levels of inclusion (0.5 and 1%) (Fig. 1b). Organosomatic indexes calculated as 
the ratio of tissue to body weight or fork length were determined for liver and intestine. The resulting hepatoso-
matic index (HSI) was enhanced significantly in fish fed 1%  LBGb diet, whereas the intestine length index (ILI) 
increased in a dose-dependent manner in fish grown-up with both products (Table 3).
Blood and tissue biochemistry. Plasma cortisol levels decreased significantly in fish fed both doses of 
 LBGb compound, whereas a clear trend, with a ~ 30% of reduction in this hormone, was also observed in both 
 LBGh groups (Table 4). Dietary supplementation did not alter plasma levels of glucose and proteins, whereas a 
lowering effect on plasma lactate was found in 0.5% and 1%  LBGb groups and in 1%  LBGh group (Table 4). Moreo-
ver, plasma triglycerides significantly increased in a dose-dependent way in fish fed both compounds  (LBGb and 
 LBGh) (Table 4). In the liver, no effects of dietary supplementation were found on the content of triglycerides and 
glucose (Table 4). However, a significant enhancement in glycogen reserves was detected in fish ingesting the 
highest dose of both supplements (1%  LBGb and 1%  LBGh) (Table 4). In the white skeletal muscle, only fish fed 
the 1%  LBGh diet experienced a significant (twofold) increase in triglyceride accumulation, whereas the content 
of glucose, glycogen, and lactate was not modified by dietary supplementation (Table 4).
Metabolic enzymes. The effect of dietary supplementation was also evaluated, both in the liver and the 
white skeletal muscle, on the activity of several metabolic enzymes related to glycogenolysis, glycolysis, gluco-
neogenesis, Krebs cycle, pentose phosphate pathway, and lipid metabolism. In the liver (Fig. 2), GPase displayed 
a significant increase with the dietary supplementation with both compounds, being more clearly regulated by 
both doses (0.5 and 1%) in its total (GPtotal) form. Hepatic HK (glycolysis) and G6PDH (pentose phosphate 
pathway) activities were enhanced significantly in fish fed the 1%  LBGh diet. An overall opposite pattern was 
detected for the gluconeogenic enzyme FBP, with the lowest activity found in livers of the 1%  LBGh group. Also, 
we observed a dose-dependent increase in LDH enzyme with both compounds. In contrast to the observations 
Table 3.  Growth performance and somatic indexes of juvenile gilthead seabream fed to visual satiety from 
February to May 2019 (13 weeks) with a control diet and four supplemented diets with 0.5% or 1% of the 
 LBGb or  LBGh microalgae-derived products. Data on body weight, feed intake and growth indexes are the 
mean ± SEM of triplicate tanks. Data on somatic indexes are the mean ± SEM of 24 fish. Different superscript 
letters in each row indicate significant differences among dietary treatments based on one-way ANOVA and 
Tukey’s test (p < 0.05). CTRL: control;  LBGb0.5: LB-GREENboost (0.5%);  LBGb1: LB-GREENboost (1%);  LBGh0.5: 
LB-GUThealth (0.5%);  LBGh1: LB-GUThealth (1%). a Values resulting from one-way analysis of variance. 
b Condition factor = (100 × body weight)/fork  length3. c Weight gain (%) = (100 × (body weigh increase)/initial 
body weight. d Specific growth rate = 100 × (ln final body weight − ln initial body weight)/days. e Hepatosomatic 
index = (100 × liver weight)/fish weight. f Intestine length index = (100 × intestine length)/fork length.
CTRL LBGb0.5 LB Gb1 LBGh0.5 LBGh1 pa
Initial body weight (g) 12.55 ± 0.04 12.64 ± 0.11 12.45 ± 0.10 12.56 ± 0.06 12.54 ± 0.05 0.650
Final body weight (g) 38.12 ± 0.89 37.97 ± 0.86 36.95 ± 1.18 37.89 ± 0.62 39.12 ± 0.36 0.519
Final fork length (cm) 14.08 ± 0.21 14.01 ± 0.25 14.29 ± 0.25 14.15 ± 0.22 14.03 ± 0.21 0.909
CFb 1.32 ± 0.05 1.30 ± 0.02 1.30 ± 1.02 1.34 ± 0.04 1.30 ± 0.02 0.835
Weight gain (%)c 203.8 ± 6.8 200.5 ± 4.4 196.8 ± 8.3 199.2 ± 5.8 208.1 ± 2.5 0.703
SGR (%)d 1.27 ± 0.03 1.26 ± 0.02 1.25 ± 0.03 1.26 ± 0.02 1.30 ± 0.01 0.610
HSI (%)e 1.01 ± 0.05a 1.16 ± 0.04ab 1.24 ± 0.04b 1.10 ± 0.07a 1.11 ± 0.04a 0.037
ILI (%)f 96.58 ± 5.09a 110.3 ± 5.09ab 128.4 ± 8.55b 111.1 ± 8.55ab 134.5 ± 6.92b  < 0.001
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made on HK activity, the glycolytic enzyme G3PDH shown a significant reduction in its hepatic activity in 
fish fed both 1%  LBGb and 0.5%  LBGh supplemented diets. No effects were found on the hepatic activity of PK 
(F = 1.096, p = 0.372), MDH (F = 0.864, p = 0.494) and HOAD (F = 0.352, p = 0.841) enzymes. In the white skeletal 
muscle (Fig. 3), LDH and G3PDH activities were significantly enhanced in fish fed with the highest dose of  LBGh, 
whereas both doses of this compound (0.5% and 1%) were able to increase HOAD activity. Moreover, a dose-
dependent increase in muscle MDH activity was detected when both compounds where used in feed. No dietary 
effects were found on the muscular activity of GPase total (F = 1.840 p = 0.343) and active (F = 0.669 p = 0.618), 
HK (F = 0.049 p = 0.995), FBP (F = 0.271 p = 0.895) and G6PDH (F = 1.969 p = 0.121) enzymes, whereas PK activ-
ity was found to be at undetectable (ND) levels in this tissue.
Muscle composition. With regard to muscle overall composition, slight, but not significant differences 
in lipid and ash contents were observed among experimental groups (Table 5). Notably, the inclusion of any 
additive in the diet yielded higher muscle total protein content compared to control group, no matter the dose 
considered, although these differences became more significant in 0.5%  LBGb fillets (Table 5).
PUFAs were the prevailing fatty acids in fish muscle at the end of the feeding trial, irrespectively of the diet 
considered (40- 41% of total FAs), followed by monounsaturated fatty acids (MUFAs, 33%), and then saturated 
fatty acids (SFAs, 20%) (Table 5). No major differences attributable to experimental diets tested were observed 
in fatty acid profiles (Table 5). However, although no differences were found in PUFA content, ALA increased 
in the muscle of all supplement-fed fish, and particularly with  LBGb at 1% (Table 5). The main overall effect of 
additive inclusion on muscle lipids can be summarized as that MUFA content increased significantly in 1%  LBGh, 
in correspondence with increased oleic acid content in this treatment (Table 5).
Figure 1.  Growth performance related to feed intake (a) and feed efficiency (b) of gilthead seabream juveniles 
fed to visual satiety from February to May 2019 (13 weeks) with a control diet and four supplemented diets 
with 0.5% or 1% of the  LBGb or  LBGh microalgae-derived products. Mean ± SEM values are shown in all 
panels. Different letters mean statistical differences after one-way ANOVA and Tukey test (p < 0.05). CTRL: 
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Discussion
Most widely application of microalgae in fish aquaculture is their use, alive or freeze-dried, to enrich zooplankton 
(i.e. rotifers and Artemia), or directly in larval culture tanks for keeping the nutritional quality of the zooplankton 
used for feeding  fish39,40. Also, because of their high content of proteins and  lipids7,8, microalgae have been evalu-
ated in different fish species as alternatives for FM and FO. High production cost of microalgal biomass remains 
the major drawback of this  strategy20, although different products (e.g. AlgaPrime DHA, Veramaris), produced 
at large-scale through fermentation-based technologies, are already being used commercially in salmon  feeds18. 
However, there is also an increasing interest in the use of microalgae as nutraceuticals in functional  feeds20,23, 
which effects can be exerted at low dietary inclusion level. The products evaluated in this work were included 
into aquafeeds at levels that can be considered low (1%) or very low (0.5%). Results showed that even at the 
lowest inclusion level, these products produce positive changes in feed efficiency, welfare and metabolism of 
gilthead seabream juveniles.
Both products,  LBGb and  LBGh, did not affect negatively the specific growth rate of gilthead seabream, the body 
weight attained by the fish, nor the survival during the trial. Likewise, a combination of microalgae in microdiets 
for larvae of the same species did not negatively affect growth and  survival17. Interestingly, both products reduced 
the feed intake and therefore increased feed efficiency. The combined analysis of growth performance (7.4–13.5% 
improvement in feed efficiency) indicates that the incorporation of these products in functional feeds for the 
gilthead seabream would reduce in up to 148 kg the amount of feed needed to produce one ton of farmed fish, 
and in saving up to 222 € per ton of fish produced, with a different balance in terms of economic issues depend-
ing on the inclusion level (Table 6), but always producing positive effects related to welfare and metabolic status 
(see below). From our results, it is apparent that these effects were achieved through common and differential 
actions of the products on fish physiology, likely as a result of their composition. While both products increased 
the length of the intestine and presumably its absorptive capacity, the higher values were observed for 1%  LBGh. 
As in other marine fish  species41, the inclusion of different microalgae in  fry42 and  juveniles43 of the gilthead sea 
bream increases enterocyte absorption surface. The same effect has been observed through dietary supplemen-
tation with Bacillus-based  probiotics44. Intestine length, on the other hand, is known to be also a plastic trait as 
shown before in this fish species in response to plant  proteins5,45 but, to the best of our knowledge, not reported 
before to respond to low or very low levels of microalgae-derived nutraceuticals such as in this work. Conversely, 
 LBGb was the only product that changed the hepatosomatic index and cortisol level in plasma, exerting this effect 
even at 0.5% inclusion in feed, and supporting that  LBGb and  LBGh exert different effects on fish metabolism.
Under stressful conditions, cortisol plays a key regulatory role in skeletal muscle metabolism, inhibiting glyco-
gen  synthesis46, and inducing the mobilization of glucose and fatty acids to overcome the stress  stimulus47. In the 
liver, cortisol also induces energy substrate repartitioning to cope with the enhanced energy demand associated 
with stressor  exposure48. However, the roles of basal level of cortisol in fish under non-stressed conditions remain 
not completed  understood49. In this regard, chronic oral administration of cortisol to gilthead seabream leads to 
higher energy expenditure and lower growth rate, increased hepatic triglycerides content and enhanced amino 
acid catabolism and gluconeogenesis in  muscle49. Conversely, low level of cortisol may stimulate GH-induced 
IGF-1 expression in fish  hepatocytes50, protein synthesis (i.e. somatic growth), and deposition of hepatic glycogen 
and lipid in the muscle of  fish49,51,52. These effects may be exerted by supplementation with microalgae-based 
products in our study, as suggested by the higher feed efficiency, higher hepatic glycogen content, and higher 
triglyceride levels in muscle of 1%  LBGb and 1%  LBGh fed fish. It is known that dietary fatty acids play important 
roles in the regulation of cortisol release in fish. For instance, in gilthead seabream, dietary deficiencies on n-3 
HUFA raised the basal plasma cortisol levels and altered the pattern of cortisol release after  stress53, and high 
Table 4.  Blood and tissue biochemistry of juvenile gilthead sea breams fed to visual satiety from February 
to May 2019 (13 weeks) with a control diet and four supplemented diets with 0.5% or 1% of the  LBGb or  LBGh 
microalgae-derived products. Data are the mean ± SEM of 12 fish. Different superscript letters in each row 
indicate significant differences among dietary treatments based on one-way ANOVA and Tukey’s test (p < 0.05). 
CTRL: control;  LBGb0.5: LB-GREENboost (0.5%);  LBGb1: LB-GREENboost (1%);  LBGh0.5: LB-GUThealth (0.5%); 
 LBGh1: LB-GUThealth (1%). a Values resulting from one-way analysis of variance.
CTRL LBGb0.5 LBGb1 LBGh0.5 LBGh1 pa
Plasma glucose (mM) 3.32 ± 0.08 3.36 ± 0.10 3.59 ± 0.12 3.42 ± 0.11 3.34 ± 0.10 0.385
Plasma lactate (mM) 4.18 ± 0.49a 2.26 ± 0.21b 2.39 ± 0.31b 2.79 ± 0.34ab 1.91 ± 0.18b 0.012
Plasma triglycerides (mM) 1.25 ± 0.08a 1.49 ± 0.17ab 1.83 ± 0.14b 1.52 ± 0.18ab 1.90 ± 0.15b 0.032
Plasma proteins (mg  mL−1) 31.54 ± 0.74 31.84 ± 0.88 30.68 ± 1.64 31.14 ± 1.07 29.44 ± 1.58 0.869
Plasma cortisol (ng  mL−1) 24.93 ± 3.01a 14.51 ± 1.71b 14.39 ± 1.89b 16.78 ± 2.70ab 17.75 ± 1.87ab 0.033
Hepatic glucose (µmol  gww−1) 0.67 ± 0.09 0.82 ± 0.11 0.62 ± 0.14 1.03 ± 0.17 0.67 ± 1.11 0.178
Hepatic glycogen (µmol  gww−1) 3.86 ± 0.34a 4.48 ± 0.23ab 5.45 ± 0.39b 4.10 ± 0.27a 5.23 ± 0.25b 0.001
Hepatic triglycerides (µmol  gww−1) 97.8 ± 11.0 99.7 ± 13.5 104.0 ± 10.3 103.6 ± 8.8 92.6 ± 7.5 0.946
Muscular glucose (µmol  gww−1) 0.19 ± 0.03 0.19 ± 0.04 0.17 ± 0.03 0.17 ± 0.03 0.19 ± 0.05 0.977
Muscular glycogen (µmol  gww−1) 0.04 ± 0.02 0.07 ± 0.03 0.09 ± 0.03 0.09 ± 0.04 0.04 ± 0.01 0.136
Muscular lactate (µmol  gww−1) 41.64 ± 2.57 49.12 ± 2.22 45.22 ± 2.63 47.98 ± 3.32 45.01 ± 2.57 0.330
Muscular triglycerides (µmol  gww−1) 17.73 ± 2.27a 19.84 ± 2.83a 18.49 ± 3.07a 24.01 ± 4.02ab 34.13 ± 5.56b 0.022
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Figure 2.  Specific activity (U mg  protein−1 as mean ± SEM) of metabolic enzymes in the liver of gilthead 
seabream juveniles fed to visual satiety from February to May 2019 (13 weeks) with a control diet and four 
supplemented diets with 0.5% or 1% of the  LBGb or  LBGh microalgae-derived products at the end of the feeding 
trial. Different letters in each panel mean statistical differences after one-way ANOVA and Tukey test (p < 0.05). 
GPase: glycogen phosphorylase (total: a, active: b), HK: hexokinase (c), G3PDH: glycerol-3-phosphate 
dehydrogenase (d), LDH: lactate dehydrogenase (e), FBP: fructose 1,6-bisphosphatase (f), G6PDH: glucose-6-
phosphate dehydrogenase (g).  CTRL: control;  LBGb0.5: LB-GREENboost (0.5%);  LBGb1: LB-GREENboost (1%); 
 LBGh0.5: LB-GUThealth (0.5%);  LBGh1: LB-GUThealth (1%).
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concentration of arachidonic acid (ARA) and eicosapentaenoic acid (EPA) reduced cortisol secretion in this 
 species54,55. However, given the low inclusion level of  LBGb in this study, it may exert its effects on cortisol levels 
through a different mechanism, that remains unknown, although it can be suggested that the lower doses of 
aquafeeds needed to accomplish apparent satiety produces a decrease in anticipatory activity that leads to improve 
the welfare status of the fish, which is clearly reflected in lower cortisol levels. Even so, whether lower levels of 
baseline cortisol in plasma also affect the response of fish to stressful condition such as high stocking density or 
handling remains unknown and deserves further investigation.
To further study the biochemical basis of the observed phenotypic outputs of microalgae-based product 
supplementation, and to better differentiate the metabolic effects of  LBGb and  LBGh, we measured the level of 
different metabolites, and the activity of several metabolic enzymes, both in the liver and white skeletal muscle. 
We observed that both products lowered plasma lactate levels, although  LBGb promoted this effect at a lower 
inclusion (0.5%) than  LBGh (1%). This result suggests that both products may favor oxidative over anaerobic 
metabolism in the white skeletal muscle, or that lactate uptake and clearance by the liver or other tissues is 
stimulated. We found no differences among treatments in glycogen, free glucose, and lactate in the white skel-
etal muscle, and the activity of LDH in muscle of all supplemented fed fish was not different to that of control 
fish, except for slightly higher values in 1%  LBGh. Thus, our observations do not sustain a lower production of 
lactate from muscle anaerobic metabolism in fish fed diets supplemented with the microalgae-based products. 
Interestingly, the higher hepatic storage of glycogen in fish fed diets supplemented with  LBGh and  LBGb at 1% 
and a trend for hepatic LDH activity to increase suggests that both products may promote the hepatic uptake 
of lactate. However, the conversion of lactate to pyruvate by LDH in the liver (i.e. Cori cycle), and its further 
conversion to glycogen, is not clear in fish. Indeed, an early study analyzing lactate metabolism in 36 fish species 
suggested that little blood lactate is taken up by the liver in  fish56, and more recent studies also suggested that 
using lactate as a precursor for liver glycogen is unlikely in  fish57. Other tissues of gilthead seabream using lactate 
as energy  source58,59 should also contribute to the clearance of  lactate57,60 and part of the lactate could return to 
the  muscle60. Our observations on plasma lactate would be also related with a decrease in the level of fish activity 
Figure 3.  Specific activity (U mg−1 protein as mean ± SEM) of metabolic enzymes in the white skeletal muscle 
of gilthead seabream juveniles fed to visual satiety from February to May 2019 (13 weeks) with a control diet 
and four supplemented diets with 0.5% or 1% of the  LBGb or  LBGh microalgae-derived products at the end of the 
feeding trial. Different letters in each panel mean statistical differences after one-way ANOVA and Tukey test 
(p < 0.05). G3PDH: glycerol-3-phosphate dehydrogenase (a), LDH: lactate dehydrogenase (b), MDH: malate 
dehydrogenase (c), HOAD: 3-hydroxyacyl-CoA dehydrogenase (d). CTRL: control;  LBGb0.5: LB-GREENboost 
(0.5%);  LBGb1: LB-GREENboost (1%);  LBGh0.5: LB-GUThealth (0.5%);  LBGh1: LB-GUThealth (1%).
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Table 5.  Effects of dietary additives on proximate composition and fatty acid profile of juvenile seabream 
muscle fed to visual satiety from February to May 2019 (13 weeks) with a control diet and four supplemented 
diets with 0.5% or 1% of the  LBGb or  LBGh microalgae-derived products. Data are the mean ± SEM of 9 fish. 
Different superscript letters in each row indicate significant differences among dietary treatments after one-way 
ANOVA and Tukey’s test (p < 0.05). CTRL: control;  LBGb0.5: LB-GREENboost (0.5%);  LBGb1: LB-GREENboost 
(1%);  LBGh0.5: LB-GUThealth (0.5%);  LBGh1: LB-GUThealth (1%). a Values resulting from one-way analysis of 
variance.
CTRL LBGb0.5 LBGb1 LBGh0.5 LBGh1 pa
Proximate composition (% dw)
Protein 75.89 ± 0.02a 79.69 ± 0.27c 78.69 ± 0.28bc 77.86 ± 0.17b 78.91 ± 0.07bc  < 0.001
Lipid 23.00 ± 0.27 24.30 ± 1.13 26.50 ± 0.83 22.70 ± 0.73 23.40 ± 0.83 0.074
Ash 5.81 ± 0.18 6.15 ± 0.18 6.06 ± 0.11 6.25 ± 0.13 5.95 ± 0.33 0.098
Moisture 76.00 ± 0.40 75.70 ± 0.37 75.50 ± 0.17 75.00 ± 0.13 74.30 ± 0.37 0.321
Fatty acid composition (% of total FAs)
14:0 2.02 ± 0.00a 2.05 ± 0.00ab 2.08 ± 0.00b 2.01 ± 0.01a 2.09 ± 0.00b 0.004
16:0 14.07 ± 0.00 14.01 ± 0.04 14.34 ± 0.01 14.22 ± 0.06 14.13 ± 0.02 0.119
18:0 4.09 ± 0.00 3.94 ± 0.02 4.06 ± 0.01 4.05 ± 0.01 4.02 ± 0.01 0.089
16:1n7 4.56 ± 0.00a 4.61 ± 0.01ab 4.65 ± 0.00ab 4.54 ± 0.00a 4.71 ± 0.01b 0.024
18:1n7 2.38 ± 0.020ab 2.38 ± 0.00ab 2.39 ± 0.00ab 2.36 ± 0.00a 2.41 ± 0.00b 0.013
18:1n9 25.30 ± 0.00ab 25.61 ± 0.02bc 25.63 ± 0.01bc 25.16 ± 0.03a 25.84 ± 0.05c 0.005
20:1n9 1.01 ± 0.00 1.02 ± 0.00 1.03 ± 0.00 1.02 ± 0.00 1.02 ± 0.00 0.309
16:2n4 0.48 ± 0.00 0.48 ± 0.01 0.48 ± 0.01 0.47 ± 0.00 0.46 ± 0.00 0.317
18:2n6 21.00 ± 0.00 20.74 ± 0.03 20.73 ± 0.03 20.82 ± 0.01 20.57 ± 0.15 0.453
18:3n3 1.16 ± 0.00a 1.43 ± 0.00b 1.74 ± 0.02c 1.44 ± 0.02b 1.45 ± 0.00b  < 0.001
16:3n4 0.47 ± 0.00 0.48 ± 0.00 0.47 ± 0.00 0.47 ± 0.00 0.47 ± 0.00 0.283
18:4n3 0.49 ± 0.00 0.49 ± 0.00 0.47 ± 0.00 0.46 ± 0.00 0.53 ± 0.03 0.410
20:4n6 1.04 ± 0.00 1.01 ± 0.01 1.04 ± 0.00 1.04 ± 0.01 0.99 ± 0.01 0.229
20:4n3 0.45 ± 0.00 0.43 ± 0.00 0.43 ± 0.01 0.44 ± 0.01 0.43 ± 0.00 0.762
20:5n3, EPA 3.30 ± 0.00 3.29 ± 0.01 3.32 ± 0.00 3.31 ± 0.01 3.29 ± 0.01 0.339
22:5n3 1.51 ± 0.00 1.49 ± 0.00 1.49 ± 0.00 1.51 ± 0.01 1.51 ± 0.00 0.218
22:6n3, DHA 12.05 ± 0.01 11.88 ± 0.03 12.06 ± 0.01 12.25 ± 0.11 12.10 ± 0.04 0.383
∑SFA 20.18 ± 0.01 20.00 ± 0.06 20.48 ± 0.02 20.28 ± 0.07 20.23 ± 0.03 0.127
∑MUFA 33.26 ± 0.02ab 33.63 ± 0.03b 33.70 ± 0.042bc 33.09 ± 0.03a 33.98 ± 0.07c 0.007
∑PUFA 40.99 ± 0.01 40.76 ± 0.01 41.29 ± 0.04 41.27 ± 0.17 40.86 ± 0.10 0.321
Other FA 4.59 ± 0.04 4.36 ± 0.06a 3.67 ± 0.01 4.42 ± 0.27 4.30 ± 0.06 0.226
∑n-3 18.95 ± 0.01 19.01 ± 0.03 19.51 ± 0.01 19.41 ± 0.15 19.30 ± 0.06 0.184
∑n-6 22.04 ± 0.00 21.75 ± 0.02 21.78 ± 0.03 21.86 ± 0.02 19.30 ± 0.06 0.416
∑n-9 26.32 ± 0.01ab 26.63 ± 0.02bc 26.66 ± 0.01bc 26.18 ± 0.03a 21.56 ± 0.16 0.006
n3/n6 0.86 ± 0.02 0.87 ± 0.00 0.90 ± 0.00 0.89 ± 0.01 0.90 ± 0.01 0.100
EPA/DHA 0.27 ± 0.00 0.28 ± 0.00 0.28 ± 0.00 0.27 ± 0.00 0.27 ± 0.00 0.276
Table 6.  Estimation of using microalgae-based products on the feed saving and global balance of feed costs 
for producing one ton of farmed fish. CTRL: control;  LBGb0.5: LB-GREENboost (0.5%);  LBGb1: LB-GREENboost 
(1%);  LBGh0.5: LB-GUThealth (0.5%);  LBGh1: LB-GUThealth (1%). a For the estimation it has been considered a 
value of 1.5€ kg  feed−1. b Estimated as cost feed saving (€ ton  fish−1) – additive cost (€ ton  fish−1).
Feed efficiency (kg 
fish kg  feed−1)
Total feed (kg feed 
ton  fish−1)
Feed saving (kg feed 
ton  fish−1)
Cost feed saving (€ 
ton  fish−1)a
Additive use (kg ton 
 fish−1)
Additive cost (€ ton 
 fish−1)
Balance (€ ton 
 fish−1)b
CTRL 0.81 1235
LBGb0.5 0.87 1149 85 128 5.75 114.9 13.1
LBGb1 0.90 1111 123 185 11.11 222.2 − 37.2
LBGh0.5 0.88 1136 98 147 5.68 113.6 33.4
LBGh1 0.92 1087 148 222 10.87 217,4 4.6
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when fed the micro-algae supplemented diets, and this may in turn be associated with decreased cortisol levels 
and improved feed efficiency as discussed above.
We also found that the inclusion of  LBGh increased hepatic HK activity, most significantly at 1% inclusion 
in feed, while PK activity was unaltered by dietary supplementation. HK is the first step in glycolysis, phospho-
rylating glucose to be used by cells, while PK catalyzes the last step of glycolysis producing pyruvate and ATP. 
Together, these results support that 1%  LBGh supplementation enhanced the liver capacity for glucose uptake, 
which seems to be stored as glycogen instead of being oxidized for energy. This inferred scenario agrees with 
reduced hepatic gluconeogenic enzyme (FBP) activity in 1%  LBGh fed fish. A non-significant trend for FBP to 
decrease activity in 1%  LBGb fed fish may explain why this fish also exhibited more hepatic glycogen than con-
trol fish. However, it remains unknown the metabolic significance of higher activities of GP in 1%  LBGh and 1% 
 LBGb groups. It would be related with the turnover of liver glycogen for glucose to be used in other metabolic 
pathways such as the synthesis of fatty acids. Increased glucose uptake by the liver, or production of glucose 
from glycogen, is known to have a stimulatory effect on the lipogenic enzymes G6PDH and MDH, which pro-
vide NADPH for the biosynthesis of fatty acids, and that this leads to a higher lipid storage or export form the 
 liver61,62. Indeed, we found for hepatic G6PDH a trend to increase its activity with microalgae supplementation, 
with higher activity for 1%  LBGh, while MDH exhibited higher values (although non-significant) in both  LBGh 
and  LBGb at 1% inclusion. The absence of differences in hepatic triglycerides stored in our study supports the 
export as the most likely fate of synthesized triglycerides, in agreement with a higher triglyceride level in plasma 
in 1%  LBGh and 1%  LBGb fed fish. This would be also the cause of increased triglyceride content in muscle of 1% 
 LBGh groups, doubling the triglyceride content of muscles of control fish. It is difficult to fully explain the effect 
of 1%  LBGh on muscle triglycerides, as fat deposition depends upon balance between various metabolic pathways 
and trade-offs among different organs. Some of our observations suggest that de novo lipogenesis (DNL) in the 
muscle might contribute to higher triglyceride content in 1%  LBGh fed fish. For instance, we observed higher 
activity for the lipogenic enzyme MDH in muscle in 1%  LBGh and 1%  LBGb, with the highest mean value induced 
by the former. MDH activity has been related to intramuscular fat content in other meat-producing  animals63. 
However, the contribution of DNL in muscle to fat accumulation is debatable in fish as it mostly takes place in 
the  liver64. Indeed, we found no evidence of differences in muscle DNL among treatments by using the DNL 
index (16:0/18:2n6 ratio = 0.7). Higher activity of G3PDH in 1%  LBGh fed fish is also in agreement with higher 
triglyceride content of muscle, as it is a marker of lipid synthesis in  fish65 and other  animals63. This enzyme pro-
duces glycerol-3-phosphate to which fatty acids are esterified, thus it is involved in the synthesis of triglycerides 
from imported fatty acids (e.g. from liver) rather than in muscle DNL. Finally, we recognize that changes in the 
triglyceride content of muscle of 1%  LBGh fed fish may also result from modifications in the metabolic fate of 
other nutrients induced by this microalgal product. For instance, in gilthead seabream, between 22 and 30% of 
the total lipid deposited may come from dietary  proteins66.
One interestingly finding of this study is the higher muscular HOAD activity, the third step of beta oxidation, 
in fish with increased muscle triglycerides (i.e. 1%  LBGh fed fish). It is known that in higher vertebrates, lipid 
availability per se increases mitochondrial fatty acid oxidative capacity in  muscle67. In fish (rainbow trout), an 
experimental high muscle fat line is known to exhibit an enhanced fatty acid oxidation  potential68. Increased 
HOAD activity in our study may be a compensatory mechanism to control excessive fat accumulation in fish 
muscles supplemented with 1%  LBGh, or might be involved in lipid remodeling within the muscle.
The total content of lipids and n-3 PUFAs did not vary across groups. This result was somewhat expected as 
experimental diet were rich in FM and FO. Yet, we observed a non-significant trend for n-3 PUFAs to increase 
with supplementation, probably derived from higher ALA (18:3n-3) content in all supplemented groups. We have 
no explanation for this increase in ALA content, but its effects might be related with the observed high protein 
content in muscle of microalgae fed fish, as ALA is known to prevent muscle wasting in higher  vertebrates69. We 
found, on the other hand, that supplementation with  LBGb both at 0.5% and 1%, and with  LBGh at 1%, resulted 
in fish muscles with higher MUFA content. This observation is in agreement with the evidenced increase in oleic 
acid content, which is the main MUFA of muscle in gilthead sea bream and other fish species (~ 70% of total 
MUFAs in rainbow  trout70). This result is also in accordance with the boost in muscle triglycerides in 1%  LBGh fed 
fish, as triglycerides are rich in MUFA. Therefore, it seems that storage lipids became slightly enriched in MUFA 
after feeding the microalgae products. Enhanced MUFA in fish muscle is thought to be positive, as long as SFA 
and n-6 PUFA do not increase, and the n-3 to n-6 ratio is not altered, as occurred in our study. Given that our 
assessment was performed in juveniles, major effects of increased MUFA and the ALA (n-3 PUFA) in muscle 
should be related with physiological processes (e.g. permeability and fluidity of membranes) and overall health 
status. In rats, dietary ALA supplementation increased the movement of lipids across the sarcolemmal membrane, 
a rate-limiting step in fatty acid oxidation, and led to higher triglyceride content and rates of fat  oxidation71, 
while it is known to have antioxidant and anti-inflammatory effects in both rats and  humans72. However, the 
use of the products evaluated in this study in finishing diets for adult gilthead sea bream farmed on diets with 
high substitution of FM and FO is worthy to be also explored. Information on the use of dietary supplements to 
increase the efficiency of finishing protocols is scarce, and their effects on muscle fatty acid composition would 
be different in fast growing juveniles (this study) and in commercial size (near harvest) fish. Moreover, given that 
in this and other fish species the content of lipids in fillet is correlated with the levels of different LC-PUFA73, and 
that 1%  LBGh increases the triglyceride content of muscle, it would result in adults with more MUFAs, and maybe 
PUFAs, per gram of fillet. Although dietary FA profiles are generally reflected in fish  muscle74–76, the significant 
increase in muscle MUFAs observed in the present study could be attributed to slightly differences in dietary 
fatty acids as a result of additive inclusion. The marginal higher content of 18:1n-9 and 18:3n-3 in the dietary 
treatments supplemented with the microalgae products might contribute to the observed increase of those fatty 
acids in the muscle of fish compared to the results obtained for the control diet (Table 2).
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In general, this study demonstrated that the use of  LBGb and  LBGh additives in gilthead seabream diets does 
not affect growth and improve feed efficiency. Different positive effects of microalgae products in feeds have 
been achieved at low level of supplementation such as 5% in  salmon77, 5–7% in  pigs78, and only 0.1–0.2% in 
broiler  chicks29. In our study, it was found that  LBGb and  LBGh exerted their positive, although different, effects 
at 0.5–1% in gilthead seabream juveniles. Given this low inclusion level in diet (e.g. 1%) and their reasonable 
cost (about 20€ per kg), the use of these products would result in saving from 85 to 148 kg of feeds per ton of 
farmed fish, which might reduce feed cost up to 33.4 € per ton of fish in the case of  LBGh (Table 6). Moreover, the 
inclusion of these microalgae-based products resulted in functional feeds that, depending on the product type 
and its inclusion level, produce low plasma cortisol level, higher hepatic glycogen content, and higher triglycer-
ides, ALA and MUFA levels in muscle. Further studies are needed to elucidate if these benefits observed under 
controlled conditions can be extended to different commercial species, challenging culture conditions (e.g. high 
stocking densities, handling, or metabolic depletion due to overwintering), or in improvements in fillet quality 
after long-term feeding. Similarly, it would be worthy to test the potential of these products to ameliorate some 
of the negative effect of high FM and FO replacement in gilthead seabream feeds, especially those targeting the 
intestine and lipid metabolism.
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